MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

What's Behind Organogenesis' Recent Stock Plunge and Q1 2026 Revenue Drop

1 day ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What's Behind zSpace's Recent Stock Plunge

1 week ago

What's Behind TruBridge's Recent Stock Plunge

1 months ago

What's Behind Zscaler's Recent Stock Plunge

2 months ago

What's Behind Centene's Recent Stock Plunge

2 months ago

Is CoreWeave Stock a Buy on the Dip as Revenue Continues to Skyrocket?

CoreWeave shares fell following the company's Q1 earnings announcement. The decline occurred despite the company's reported revenue growth, signaling potential investor caution regarding valuation or ...

CRWV

Stock News•1 day ago

Organogenesis Q1 Earnings Call Highlights

Organogenesis (ORGO) reported a sharp year-over-year revenue decline in Q1 2026. The downturn follows significant disruption in the skin substitute market caused by recent Medicare policy changes and ...

ORGO

Stock News•4 days ago

Why Embecta Stock Plummeted Today

Embecta shares fell after the company reported fiscal Q2 sales and earnings that missed analyst expectations. The weaker-than-anticipated results highlight significant operational headwinds for the me...

EMBC

Stock News•6 days ago

Origin Materials Stock Craters As Board Moves To Sell Technology, Wind Down Operations

Origin Materials (ORGN) shares fell sharply Monday after the company announced a strategic plan to sell its core technology and wind down operations. The decision marks a significant shift in the firm...

ORGN